Literature DB >> 23224682

Shift from phasic to tonic GABAergic transmission following laser-lesions in the rat visual cortex.

Barbara Imbrosci1, Ute Neubacher, Robin White, Ulf T Eysel, Thomas Mittmann.   

Abstract

Reduction in the strength of GABAergic neurotransmission has often been reported following brain lesions. This weakened inhibition is believed to influence neurological deficits, neuronal hyperexcitability and functional recovery after brain injuries. Uncovering the mechanisms underlying the altered inhibition is therefore crucial. In the present study we used an ex vivo-in vitro model of laser lesions in the rat visual cortex to characterize the cellular correlates of changes in GABAergic transmission in the tissue adjacent to the injury. In the first week post-injury the number of VGAT positive GABAergic terminals as well as the expression level of the GABA synthesizing enzymes GAD67 and GAD65 remained unaltered. However, a reduced frequency of miniature inhibitory postsynaptic currents (mIPSCs) together with an increased paired-pulse ratio (PPR) of evoked IPSCs suggested a functional reduction of phasic GABA release. In parallel, we found an enhancement in the GABAA receptor-mediated tonic inhibition. On the basis of these findings, we propose that cortical lesions provoke a shift in GABAergic transmission, decreasing the phasic and reinforcing the tonic component. We therefore suggest that it is not, as traditionally assumed, the overall inhibitory strength to be primarily compromised by a cortical lesion but rather the temporal accuracy of the GABAergic synaptic signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224682     DOI: 10.1007/s00424-012-1191-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  41 in total

Review 1.  Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore.

Authors:  George B Richerson; Yuanming Wu
Journal:  J Neurophysiol       Date:  2003-09       Impact factor: 2.714

2.  Metaplasticity of horizontal connections in the vicinity of focal laser lesions in rat visual cortex.

Authors:  B Imbrosci; U T Eysel; T Mittmann
Journal:  J Physiol       Date:  2010-10-20       Impact factor: 5.182

Review 3.  Palmitoylation cycles and regulation of protein function (Review).

Authors:  Steinnunn Baekkeskov; Jamil Kanaani
Journal:  Mol Membr Biol       Date:  2009-01-30       Impact factor: 2.857

4.  Periinfarct and remote excitability changes after transient middle cerebral artery occlusion.

Authors:  T Neumann-Haefelin; O W Witte
Journal:  J Cereb Blood Flow Metab       Date:  2000-01       Impact factor: 6.200

5.  GAT1 (GABA:Na+:Cl-) cotransport function. Steady state studies in giant Xenopus oocyte membrane patches.

Authors:  C C Lu; D W Hilgemann
Journal:  J Gen Physiol       Date:  1999-09       Impact factor: 4.086

6.  Increased propensity to seizures after chronic cortical deafferentation in vivo.

Authors:  Dragos A Nita; Youssouf Cissé; Igor Timofeev; Mircea Steriade
Journal:  J Neurophysiol       Date:  2005-10-19       Impact factor: 2.714

7.  GABAergic inhibition in visual cortical plasticity.

Authors:  Alessandro Sale; Nicoletta Berardi; Maria Spolidoro; Laura Baroncelli; Lamberto Maffei
Journal:  Front Cell Neurosci       Date:  2010-03-31       Impact factor: 5.505

8.  Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters.

Authors:  Jamil Kanaani; Julia Kolibachuk; Hugo Martinez; Steinunn Baekkeskov
Journal:  J Cell Biol       Date:  2010-08-30       Impact factor: 10.539

9.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.

Authors:  Andrew N Clarkson; Ben S Huang; Sarah E Macisaac; Istvan Mody; S Thomas Carmichael
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

10.  Desensitization and binding properties determine distinct alpha1beta2gamma2 and alpha3beta2gamma2 GABA(A) receptor-channel kinetic behavior.

Authors:  Andrea Barberis; Jerzy W Mozrzymas; Pavel I Ortinski; Stefano Vicini
Journal:  Eur J Neurosci       Date:  2007-05       Impact factor: 3.386

View more
  7 in total

1.  Loss of GABAB -mediated interhemispheric synaptic inhibition in stroke periphery.

Authors:  Bojana Kokinovic; Paolo Medini
Journal:  J Physiol       Date:  2018-04-17       Impact factor: 5.182

2.  Brief Dark Exposure Reduces Tonic Inhibition in Visual Cortex.

Authors:  Shiyong Huang; Kristen Hokenson; Sabita Bandyopadhyay; Shelley J Russek; Alfredo Kirkwood
Journal:  J Neurosci       Date:  2015-12-02       Impact factor: 6.167

3.  Enhanced postsynaptic inhibitory strength in hippocampal principal cells in high-performing aged rats.

Authors:  Trinh Tran; Michela Gallagher; Alfredo Kirkwood
Journal:  Neurobiol Aging       Date:  2018-06-12       Impact factor: 4.673

4.  Population receptive field analysis of the primary visual cortex complements perimetry in patients with homonymous visual field defects.

Authors:  Amalia Papanikolaou; Georgios A Keliris; T Dorina Papageorgiou; Yibin Shao; Elke Krapp; Eleni Papageorgiou; Katarina Stingl; Anna Bruckmann; Ulrich Schiefer; Nikos K Logothetis; Stelios M Smirnakis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-03       Impact factor: 11.205

5.  Focal cortical lesions induce bidirectional changes in the excitability of fast spiking and non fast spiking cortical interneurons.

Authors:  Barbara Imbrosci; Angela Neitz; Thomas Mittmann
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

6.  Nonlinear population receptive field changes in human area V5/MT+ of healthy subjects with simulated visual field scotomas.

Authors:  Amalia Papanikolaou; Georgios A Keliris; Sangkyun Lee; Nikos K Logothetis; Stelios M Smirnakis
Journal:  Neuroimage       Date:  2015-07-03       Impact factor: 6.556

Review 7.  Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models.

Authors:  Kiyoshi Egawa; Atsuo Fukuda
Journal:  Front Neural Circuits       Date:  2013-10-24       Impact factor: 3.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.